These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12895691)

  • 1. DNA encapsidation as a target for anti-herpesvirus drug therapy.
    Visalli RJ; van Zeijl M
    Antiviral Res; 2003 Jul; 59(2):73-87. PubMed ID: 12895691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpesviridae and novel inhibitors.
    Siakallis G; Spandidos DA; Sourvinos G
    Antivir Ther; 2009; 14(8):1051-64. PubMed ID: 20032535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermolecular Complementation between Two Varicella-Zoster Virus pORF30 Terminase Domains Essential for DNA Encapsidation.
    Visalli MA; House BL; Lahrman FJ; Visalli RJ
    J Virol; 2015 Oct; 89(19):10010-22. PubMed ID: 26202238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidine kinase and protein kinase in drug-resistant herpesviruses: Heads of a Lernaean Hydra.
    Topalis D; Gillemot S; Snoeck R; Andrei G
    Drug Resist Updat; 2018 Mar; 37():1-16. PubMed ID: 29548479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms.
    Gilbert C; Bestman-Smith J; Boivin G
    Drug Resist Updat; 2002 Apr; 5(2):88-114. PubMed ID: 12135584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and potential therapies for the treatment of herpesvirus infections.
    Villarreal EC
    Prog Drug Res; 2001; 56():77-120. PubMed ID: 11417115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and potential therapies for the treatment of herpes-virus infections.
    Villarreal EC
    Prog Drug Res; 2003; 60():263-307. PubMed ID: 12790345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DNA helicase-primase complex as a target for herpes viral infection.
    Weller SK; Kuchta RD
    Expert Opin Ther Targets; 2013 Oct; 17(10):1119-32. PubMed ID: 23930666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of herpesvirus and influenza virus replication by blocking polymerase subunit interactions.
    Palù G; Loregian A
    Antiviral Res; 2013 Sep; 99(3):318-27. PubMed ID: 23748148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of protein kinase inhibitors for treating herpesvirus-associated disease.
    Li R; Hayward SD
    Trends Microbiol; 2013 Jun; 21(6):286-95. PubMed ID: 23608036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
    Reusser P
    J Hosp Infect; 1996 Aug; 33(4):235-48. PubMed ID: 8864937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of new antivirals for herpesviruses.
    Eizuru Y
    Antivir Chem Chemother; 2003 Nov; 14(6):299-308. PubMed ID: 14968936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Update on new antiviral drug development for human herpesviruses].
    Inoue N; Hashimoto K; Fukuchi S
    Nihon Rinsho; 2012 Apr; 70(4):642-8. PubMed ID: 22568147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-nucleoside inhibitors of herpesviruses.
    Wathen MW
    Rev Med Virol; 2002; 12(3):167-78. PubMed ID: 11987142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymerase.
    Topalis D; Gillemot S; Snoeck R; Andrei G
    Nucleic Acids Res; 2016 Nov; 44(20):9530-9554. PubMed ID: 27694307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antivirals for herpesviruses and cytomegalovirus].
    Minematsu T
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():396-400. PubMed ID: 17455652
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioactive activities of natural products against herpesvirus infection.
    Son M; Lee M; Sung GH; Lee T; Shin YS; Cho H; Lieberman PM; Kang H
    J Microbiol; 2013 Oct; 51(5):545-51. PubMed ID: 24173639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and development of antivirals and intervention strategies against human herpesviruses using high-throughput approach.
    Hornig J; McGregor A
    Expert Opin Drug Discov; 2014 Aug; 9(8):891-915. PubMed ID: 25003658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms of antiviral resistance among the herpesvirus group].
    Reina J
    Enferm Infecc Microbiol Clin; 1997; 15(6):329-34. PubMed ID: 9376408
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitors of dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) exert a strong anti-herpesviral activity.
    Hutterer C; Milbradt J; Hamilton S; Zaja M; Leban J; Henry C; Vitt D; Steingruber M; Sonntag E; Zeitträger I; Bahsi H; Stamminger T; Rawlinson W; Strobl S; Marschall M
    Antiviral Res; 2017 Jul; 143():113-121. PubMed ID: 28400201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.